Literature DB >> 12583565

Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method.

Jerzy Walecki1, Eugeniusz Tarasów, Bozena Kubas, Zbigniew Czemicki, Janusz Lewko, Jan Podgórski, Maria Sokól, Pawel Grieb.   

Abstract

RATIONALE AND
OBJECTIVES: The determination of tumor boundaries, especially in high-grade glioma, is critically important for the proper planning of treatment, but the standard diagnostic imaging methods do not enable precise delimitation of the extent of tumor cell infiltration into the surrounding tissue. The objective of this study was to assess the usefulness of hydrogen-1 (H-1) magnetic resonance (MR) spectroscopy for determining the extent of gliomatous infiltrate in the "uncertain zone'--the peritumoral area that appears unchanged on standard diagnostic MR images.
MATERIALS AND METHODS: The study group consisted of 64 patients with cerebral glioma scheduled for tumor resection and subsequent radiation therapy. All patients were examined prior to resection with MR imaging and MR spectroscopy. MR spectra were obtained from examination of the solid part of the tumor and from two peritumoral volumes of interest located approximately along the axis of surgical access to the tumor. MR spectra obtained from a group of 32 healthy volunteers were used as control data.
RESULTS: Analysis of the consequent voxels in the peritumoral zone revealed statistically significant differences in lipid/creatine and lactate/creatine metabolite ratios between patient subgroups with recurrent malignant lesions and without recurrent lesions. Significant differences also were found between the patient group and the control group in most metabolite ratios assessed.
CONCLUSION: H-1 MR spectroscopic demonstration of metabolic changes in the peritumoral zone can guide treatment for cerebral glioma, enabling the physician to identify patients who have a high risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12583565     DOI: 10.1016/s1076-6332(03)80038-7

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  9 in total

Review 1.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Microsurgery for malignant gliomas.

Authors:  M Gazi Yaşargil; Paulo A S Kadri; Dianne C H Yasargil
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging.

Authors:  Ilwoo Park; Robert Bok; Tomoko Ozawa; Joanna J Phillips; C David James; Daniel B Vigneron; Sabrina M Ronen; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

4.  TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells.

Authors:  Zhang Peng; Yue Shuangzhu; Jiang Yongjie; Zhang Xinjun; Liu Ying
Journal:  Mol Cell Biochem       Date:  2013-01-29       Impact factor: 3.396

5.  Proton MR spectroscopy in mild traumatic brain injury.

Authors:  Bożena Kubas; Wojciech Lebkowski; Urszula Lebkowska; Wojciech Kułak; Eugeniusz Tarasow; Jerzy Walecki
Journal:  Pol J Radiol       Date:  2010-10

6.  Comments and controversies: magnetic resonance spectroscopy and gliomas.

Authors:  Guoguang Fan
Journal:  Cancer Imaging       Date:  2006-09-07       Impact factor: 3.909

7.  Transient Changes in Brain Metabolites after Transcranial Direct Current Stimulation in Spastic Cerebral Palsy: A Pilot Study.

Authors:  Paradee Auvichayapat; Benchaporn Aree-Uea; Narong Auvichayapat; Warinthorn Phuttharak; Taweesak Janyacharoen; Orathai Tunkamnerdthai; Wuttisak Boonphongsathian; Niran Ngernyam; Keattichai Keeratitanont
Journal:  Front Neurol       Date:  2017-07-31       Impact factor: 4.003

8.  Brain Metabolite Changes After Anodal Transcranial Direct Current Stimulation in Autism Spectrum Disorder.

Authors:  Narong Auvichayapat; Niramol Patjanasoontorn; Warinthorn Phuttharak; Chanyut Suphakunpinyo; Keattichai Keeratitanont; Orathai Tunkamnerdthai; Benchaporn Aneksan; Wanalee Klomjai; Wuttisak Boonphongsathian; Akkharawat Sinkueakunkit; Wiyada Punjaruk; Somsak Tiamkao; Paradee Auvichayapat
Journal:  Front Mol Neurosci       Date:  2020-06-04       Impact factor: 5.639

9.  Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma.

Authors:  Zahra Alirezaei; Alireza Amouheidari; Masoud Hassanpour; Fariba Davanian; Sajjad Iraji; Parvaneh Shokrani; Mohammad-Reza Nazem-Zadeh
Journal:  Biomed Res Int       Date:  2021-03-04       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.